文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

宫颈癌国际多中心放射肿瘤学研究的大规模数据分析工具

Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer.
PubMed 文献 · Radiother Oncol · 2023-02-09

本研究开发并测试了一款数据仪表板软件,在正在进行的EMBRACE-II研究中用于局部晚期宫颈癌,实现机构患者、治疗和结局数据与参考队列的定量与定性比较,并自动核查方案依从性与数据不一致性。共识别2302项质量保证事件(占全部收集数据的0.4%),519/1001(52%)的患者至少存在一项质量保证事件,与主要研究终点相关的质量保证事件见于16%的患者。统计方法检测异常表现良好,精确度范围为71%至100%。

要点

  • 软件工具在EMBRACE-II试验中测试,可对机构数据进行定量与定性比较并自动核查方案依从性。
  • 共识别2302项质量保证事件(占全部数据0.4%),519/1001(52%)患者至少有一项事件。
  • 统计方法检测异常的精确度范围为71%至100%。

核心结论

  • 开发并在一项放射肿瘤学临床试验中测试了一款软件工具,可实现机构患者与治疗参数同大型多中心参考队列的定量和定性比较。
  • 研究展示了使用统计方法自动检测不合理数据点的价值,并揭示了宫颈癌放疗中常见的陷阱与不确定性。

研究设计与样本

  • 设计了一款综合数据仪表板,用于整体评估机构治疗方式,并在正在进行的EMBRACE-II研究(局部晚期宫颈癌)中测试该软件。
  • 该工具生成个体化仪表板和自动分析脚本,核查方案依从性并检查数据不一致性,对识别出的质量保证事件进行分析,并对用户开展可用性调查。

主要发现

  • 共识别2302项质量保证事件(占全部收集数据的0.4%),其中54%由数据缺失或不完整导致,46%源于其他原因。
  • 519/1001(52%)的患者至少发现一项质量保证事件,与主要研究终点相关的质量保证事件见于16%的患者。
  • 统计方法检测异常表现良好,精确度范围为71%至100%。
  • 最常见的质量保证事件类别为治疗技术(27%)、患者特征(22%)、剂量报告(17%)、结局156(15%)、离群值(12%)和放疗结构(8%)。
  • 用户调查显示对原型反馈良好,并强调了其用于内部监测的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop and implement a software that enables centers, treating patients with state-of-the-art radiation oncology, to compare their patient, treatment, and outcome data to a reference cohort, and to assess the quality of their treatment approach. MATERIALS AND METHODS: A comprehensive data dashboard was designed, which al- lowed holistic assessment of institutional treatment approaches. The software was tested in the ongoing EMBRACE-II study for locally advanced cervical cancer. The tool created individualized dashboards and automatic analysis scripts, verified pro- tocol compliance and checked data for inconsistencies. Identified quality assurance (QA) events were analysed. A survey among users was conducted to assess usability. RESULTS: The survey indicated favourable feedback to the prototype and highlighted its value for internal monitoring. Overall, 2302 QA events were identified (0.4% of all collected data). 54% were due to missing or incomplete data, and 46% originated from other causes. At least one QA event was found in 519/1001 (52%) of patients. QA events related to primary study endpoints were found in 16% of patients. Sta- tistical methods demonstrated good performance in detecting anomalies, with precisions ranging from 71% to 100%. Most frequent QA event categories were Treatment Technique (27%), Patient Characteristics (22%), Dose Reporting (17%), Outcome 156 (15%), Outliers (12%), and RT Structures (8%). CONCLUSION: A software tool was developed and tested within a clinical trial in radia- tion oncology. It enabled the quantitative and qualitative comparison of institutional patient and treatment parameters with a large multi-center reference cohort. We demonstrated the value of using statistical methods to automatically detect implau- sible data points and highlighted common pitfalls and uncertainties in radiotherapy for cervical cancer.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Ecker S, Kirisits C, Schmid M, et al. Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer. Radiother Oncol. 2023. PMID: 36764459. doi:10.1016/j.radonc.2023.109524

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。